{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-22-020412","form_type":"8-K","ticker":"VTAK","cik":"0001716621","company_name":"Catheter Precision, Inc.","filed_at":"2022-05-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:01.973621+00:00","generated_at":"2026-06-25T15:06:10.951472+00:00","sec_items":["2.02","5.02","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ra Medical Systems reports Q1 loss of $5.5M, CFO Andrew Jackson resigns","bullets":["Revenue of $9,000 in Q1 2022, up from $4,000 in Q1 2021; minimal product sales.","Loss from continuing operations $5.5M ($0.27 per share) vs $6.9M ($2.36) a year ago.","CFO Andrew Jackson to resign effective May 25, 2022; resignation not due to any disagreement.","Enrolled 107 of 125 subjects in pivotal atherectomy trial; filed 510(k) for next-gen DABRA 2.0 catheter.","Completed public offering for ~$9.7M net proceeds; engaged investment bank to review strategic alternatives."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-22-020412","json":"https://secwatch.observer/filing/0001564590-22-020412.json","markdown":"https://secwatch.observer/filing/0001564590-22-020412.md","text":"https://secwatch.observer/filing/0001564590-22-020412.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1716621/000156459022020412/0001564590-22-020412-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1716621/000156459022020412/rmed-8k_20220510.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-25T15:06:10.951472+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"39ff0650e8","claim":"Andrew Jackson departed as Chief Financial Officer and Secretary at Catheter Precision, Inc..","evidence_excerpt":"On May 10, 2022, Andrew Jackson notified Ra Medical Systems, Inc. (the “Company”) that he will resign as the Company’s Chief Financial Officer and Secretary, effective May 25, 2022.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1716621/000156459022020412/0001564590-22-020412-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"resign"},{"label":"Role","value":"Chief Financial Officer and Secretary"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}